Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iron Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116768938B reveals iron catalyst technology for Rimegepant intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel patent CN104045592A details mild synthesis of 5-fluoroindole-2-one. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel FeX3 catalyzed method for pyrroles replaces noble metals. High purity, green chemistry, and cost-effective solutions for API manufacturing.
Patent CN117126077B reveals a green visible-light iron catalyzed route for 4-arylbutyronitrile. Achieve 100% atom economy and cost reduction in fine chemical manufacturing.
Novel visible light iron catalysis method for 4-arylbutyronitrile. Offers 100% atom economy and mild conditions for scalable pharmaceutical intermediate manufacturing.
Simplify 1,2,4-triazole synthesis with this iron-catalyzed method. No anhydrous conditions, high yields, and easy scale-up for drug development. Reduce costs and risks.
Solve 4-arylbutyronitrile synthesis challenges with 100% atom economy, room-temperature visible light iron catalysis. Eliminate noble metals, reduce waste. Scale to 100MT/yr.
Discover how iron-catalyzed cyclopropyl borate synthesis reduces costs and supply chain risks for pharmaceutical intermediates. Contact us for scalable production.
Discover a scalable, eco-friendly synthesis route for KRAS inhibitor intermediate with 33% yield. Reduce costs and supply chain risks for your API production.
Solve 1,2,4-triazole synthesis challenges with iron-catalyzed method. Eliminate anhydrous conditions, reduce costs, and ensure scalable production for drug development.
Discover how iron-catalyzed pyrrole synthesis reduces costs by 70% vs. noble metals, with high yields (80-90%) and simplified purification for your API production.